The U.S. Food and Drug Administration today cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM) for children, Dexcom Inc.’s Stelo Glucose Biosensor System, an integrated CGM (iCGM) indicated for people two years of age and older who do not use insulin.
Healthcare
FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children
Source: FDA Press Releases — US Government, Public Domain